IMB Dx, Inc. (KOSDAQ:461030)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,135.00
-110.00 (-2.59%)
Jun 10, 2026, 3:30 PM KST

IMB Dx Revenue

IMB Dx had revenue of 1.27B KRW in the quarter ending March 31, 2026, with 27.06% growth. This brings the company's revenue in the last twelve months to 5.60B, up 59.65% year-over-year. In the year 2025, IMB Dx had annual revenue of 5.33B with 56.40% growth.

Revenue (ttm)
5.60B
Revenue Growth
+59.65%
P/S Ratio
10.63
Revenue / Employee
n/a
Employees
n/a
Market Cap
59.51B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.33B1.92B56.40%
Dec 31, 20243.41B-619.97M-15.40%
Dec 31, 20234.03B1.40B53.42%
Dec 31, 20222.62B1.39B113.34%
Dec 31, 20211.23B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Macrogen199.60B
ORIENT BIO59.09B
Amicogen43.44B
CG Invites29.22B
GeneOne Life Science17.12B
Prestige BioPharma16.21B
iNtRON Biotechnology5.74B
MedPacto4.79B
Revenue Rankings